Seeking Alpha

Cancer Genetics, Inc. (CGIX)

  • Eric Muathe | Send Message 2 Jul

    [VIDEO] $STUDY Secondary Breakout Levels Part 2 $CGIX $GWPH $DXYN $FEYE $GLOG $MDGN $CNC $TCS $CSIQ $NVAX
      • sr912 | Send Message 3 Apr

        Some tech analysis on $CGIX at the link below
          • sr912 | Send Message 3 Apr
              • Eric Muathe | Send Message 19 Feb
                  • Life Sciences Report | Send Message 18 Dec 2014

                    "Pappajohn's show of faith in $CGIX speaks volumes about its potential"-RedChip Money Report. Read:
                      • RedChip | Send Message 16 Dec 2014

                        Why These Five Healthcare Stocks Have The Potential For 100% Gains In 2015 $CGIX, $OPXA, $ATNM
                        Reply (1)
                        • BiotechX | Send Message 6 Jan
                          : Why just 100% for $OPXA? The potential for OPXA is much higher? Hoe likely is that they suceed in PII?
                          • Life Sciences Report | Send Message 11 Dec 2014

                            "We believe $CGIX's revenues will continue to grow in coming quarters"-Yi Chen. Read More:
                              • RedChip | Send Message 4 Dec 2014

                                RedChip Receives Top Praise For Its Performance $CGIX, $PFIE, $NDAQ
                                  • BiotechX | Send Message 3 Dec 2014

                                    $CGIX is valued now at $10M considering market cap - cash...really bad
                                      • BiotechX | Send Message 2 Dec 2014

                                        $CGIX - I guess the market is waiting for higher revenues and reduced cash can last to make the business profitable.
                                          Visit Seeking Alpha's
                                          CGIX vs. ETF Alternatives
                                          Company Description
                                          Cancer Genetics Inc is an early-stage diagnostics company focused on developing and commercializing proprietary genomic tests and engages in improving and personalizing the diagnosis, prognosis and response to treatment of cancer.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States